345 filings
Page 5 of 18
8-K
i58tx sbg8
3 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:32am
425
g1zm9et
3 Jun 19
Business combination disclosure
8:31am
8-K/A
8m6ap4f
13 May 19
Entry into a Material Definitive Agreement
9:43am
425
jb9mzw20pexzkt3kspv4
13 May 19
Business combination disclosure
9:41am
8-K
tw8m3e
13 May 19
Entry into a Material Definitive Agreement
7:41am
425
dxlehl6 ws6
13 May 19
Business combination disclosure
7:39am
8-K
h7q4f ge9
6 May 19
Termination of a Material Definitive Agreement
4:30pm
8-K
uumb38yzisi4dy w6
18 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
425
6aj4bf yp
18 Apr 19
Business combination disclosure
4:16pm
425
tdk szj1cc9wqg8
8 Apr 19
Business combination disclosure
4:34pm
8-K
lt0r6 0qyl09nrn4
8 Apr 19
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage
7:17am
425
jqn5z9yrv
8 Apr 19
Business combination disclosure
7:15am
8-K
cptpz sj5lucfoba
15 Mar 19
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
ibofo
5 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
v7s8q8jl9pbr
25 Feb 19
Departure of Directors or Certain Officers
8:30am
SC 13G/A
p6nwue4i21ky zoroa
14 Feb 19
Histogenics Corp
2:40pm
SC 13G/A
y41eo8
14 Feb 19
Histogenics Corp
12:00am
SC 13D/A
zjw9wod
12 Feb 19
Histogenics Corp
4:15pm